Chrispin Kambili is an Infectious Disease physician affiliated with Johnson & Johnson. OpenAlex indexes 40 publications with 307 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20251 payment
- Janssen Research & Development, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2010–2011 per NIH RePORTER. The latest:
- TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
New York City Health/mental Hygiene
FY2011$8,599,199U52PS200462 - TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
New York City Health/mental Hygiene
FY2010$8,993,816U52PS200462
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB
The International Journal of Tuberculosis and Lung Disease
2022 - Bedaquiline for multidrug-resistant TB in paediatric patients
The International Journal of Tuberculosis and Lung Disease
2021 - The cost-effectiveness of a bedaquiline-containing short-course regimen for the treatment of multidrug-resistant tuberculosis in South Africa
Expert Review of Anti-infective Therapy
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Balaji Laxmanan, MD
Johnson & Johnson
Marvin Sperling, MD
Johnson & Johnson
Wayne Drevets, MD
Johnson & Johnson
Hanneke Schuitemaker
Johnson & Johnson
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”